We have advised several clients on the conduct and defence of complaints made to the Dutch Advertising Committee regarding claims about products such as foods, pharmaceuticals and medical devices across Dutch media.
Updates
Explore our latest insights, regulatory updates, and strategic reports for the life sciences sector.
Type (1)
Sectors (2)
Expertises
25 results
Newest first
We have advised a client on collaborations between pharmaceutical companies and healthcare providers and contract research organisations, including the negotiation of framework agreements for clinical research.
We have assisted a pharmaceutical company with the alignment of its promotional materials with applicable codes of conduct.
We have advised a large pharmaceutical company on the conduct of combined studies in collaboration with IVD manufacturers.
We have assisted a large company in setting up a patient support program.
We have litigated in a pharmaceutical case concerning the validity of marketing authorisations.
We regularly assist clients with pricing and reimbursement procedures in the Netherlands.
We have negotiated clinical trial agreements on behalf of several sponsors.
We have assisted a diagnostics company with its companion diagnostics strategy, including the regulatory implications of combining diagnostic and therapeutic products.
Axon regularly advises spin-outs from academic institutions on a wide range of topics. We make sure that the spin-out’s license agreement includes commercially and legally viable terms and is attractive to investors. In addition, we advise on the corporate structure of the spin-out, balancing the interest of the founders, the academic institution and all other stakeholders.